Megan Maxwell

1.0k total citations
11 papers, 828 citations indexed

About

Megan Maxwell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Megan Maxwell has authored 11 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 2 papers in Physiology. Recurrent topics in Megan Maxwell's work include Peroxisome Proliferator-Activated Receptors (7 papers), RNA modifications and cancer (5 papers) and Nuclear Receptors and Signaling (4 papers). Megan Maxwell is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), RNA modifications and cancer (5 papers) and Nuclear Receptors and Signaling (4 papers). Megan Maxwell collaborates with scholars based in Australia and United States. Megan Maxwell's co-authors include George E.O. Muscat, Denis I. Crane, Barbara C. Paton, Annika Stark, Gregory J. Cooney, Mark E. Cleasby, Angus Harding, Gordon S. Lynch, Michael A. Pearen and James G. Ryall and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Endocrinology.

In The Last Decade

Megan Maxwell

11 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan Maxwell Australia 10 471 471 255 123 87 11 828
L. John Andrews United States 5 719 1.5× 474 1.0× 93 0.4× 151 1.2× 29 0.3× 8 1.2k
Shin‐ichiro Sano Japan 16 330 0.7× 180 0.4× 235 0.9× 130 1.1× 36 0.4× 30 686
Chee H. Ng Singapore 15 414 0.9× 166 0.4× 214 0.8× 136 1.1× 32 0.4× 20 853
Debra A. Horstman United States 13 862 1.8× 418 0.9× 85 0.3× 112 0.9× 36 0.4× 15 1.0k
Pascal Merchiers Belgium 9 364 0.8× 146 0.3× 87 0.3× 259 2.1× 34 0.4× 18 638
Thomas McAvoy United States 14 601 1.3× 176 0.4× 58 0.2× 89 0.7× 49 0.6× 19 822
Lucie Janečková Czechia 16 397 0.8× 269 0.6× 53 0.2× 138 1.1× 47 0.5× 29 846
C. Southern United Kingdom 11 313 0.7× 129 0.3× 91 0.4× 166 1.3× 188 2.2× 12 730
Laura Hertwig Sweden 8 362 0.8× 124 0.3× 155 0.6× 201 1.6× 17 0.2× 9 650
Richard D. Peavy United States 9 468 1.0× 258 0.5× 312 1.2× 208 1.7× 18 0.2× 10 915

Countries citing papers authored by Megan Maxwell

Since Specialization
Citations

This map shows the geographic impact of Megan Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Maxwell more than expected).

Fields of papers citing papers by Megan Maxwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Maxwell. The network helps show where Megan Maxwell may publish in the future.

Co-authorship network of co-authors of Megan Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Maxwell. A scholar is included among the top collaborators of Megan Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Maxwell. Megan Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sahai, Sunil K., Konstantin Balonov, Dennis M. Bierle, et al.. (2022). Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement. Mayo Clinic Proceedings. 97(9). 1734–1751. 8 indexed citations
2.
Pearen, Michael A., James G. Ryall, Megan Maxwell, et al.. (2006). The Orphan Nuclear Receptor, NOR-1, Is a Target of β-Adrenergic Signaling in Skeletal Muscle. Endocrinology. 147(11). 5217–5227. 105 indexed citations
3.
Maxwell, Megan & George E.O. Muscat. (2006). The NR4A Subgroup: Immediate Early Response Genes with Pleiotropic Physiological Roles. PubMed. 4(1). e002–e002. 356 indexed citations
4.
Maxwell, Megan, et al.. (2005). NovelPEX1 coding mutations and 5′ UTR regulatory polymorphisms. Human Mutation. 26(3). 279–279. 14 indexed citations
5.
Maxwell, Megan, Mark E. Cleasby, Angus Harding, et al.. (2005). Nur77 Regulates Lipolysis in Skeletal Muscle Cells. Journal of Biological Chemistry. 280(13). 12573–12584. 140 indexed citations
6.
Crane, Denis I., Megan Maxwell, & Barbara C. Paton. (2005). PEX1mutations in the Zellweger spectrum of the peroxisome biogenesis disorders. Human Mutation. 26(3). 167–175. 23 indexed citations
7.
Maxwell, Megan, Jonas Björkman, Tam Nguyen, et al.. (2003). Pex13Inactivation in the Mouse Disrupts Peroxisome Biogenesis and Leads to a Zellweger Syndrome Phenotype. Molecular and Cellular Biology. 23(16). 5947–5957. 91 indexed citations
8.
Björkman, Jonas, Ian D. Tonks, Megan Maxwell, et al.. (2002). Conditional inactivation of the peroxisome biogenesis Pex13 gene by Cre‐loxP excision. genesis. 32(2). 179–180. 12 indexed citations
9.
Maxwell, Megan, et al.. (2002). NovelPEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis disorder patients. Human Mutation. 20(5). 342–351. 31 indexed citations
10.
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026